» Authors » S Lastere

S Lastere

Explore the profile of S Lastere including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 877
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Beau F, Lastere S, Mallet H, Mauguin S, Broult J, Laperche S
Transfus Clin Biol . 2020 Jan; 27(1):4-9. PMID: 31889619
Background: Several successive arbovirus outbreaks have affected French Polynesia (FP) in the recent past years due to different dengue serotypes (DENV) present for several decades, Zika (ZIKV) (2013-2014) and chikungunya...
2.
Bouscaren N, Benoit de Coignac C, Lastere S, Musso D, Teissier Y, Formont J, et al.
New Microbes New Infect . 2019 Mar; 29:100518. PMID: 30899522
Leptospirosis is a worldwide zoonosis with higher incidence in tropical areas and is a neglected disease in the Pacific region. French Polynesia (FP) is a French overseas territory located in...
3.
Le Guern A, Eftekhari-Hassanlouie S, Lastere S, Beaugendre E, Oehler E
Med Mal Infect . 2015 Jun; 45(7):301-2. PMID: 26089216
No abstract available.
4.
Besnard M, Lastere S, Teissier A, Cao-Lormeau V, Musso D
Euro Surveill . 2014 Apr; 19(13). PMID: 24721538
No abstract available.
5.
Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastere S, Valour F, et al.
Euro Surveill . 2014 Mar; 19(9). PMID: 24626205
Zika fever, considered as an emerging disease of arboviral origin, because of its expanding geographic area, is known as a benign infection usually presenting as an influenza-like illness with cutaneous...
6.
Damond F, Brun-Vezinet F, Matheron S, Peytavin G, Campa P, Pueyo S, et al.
J Clin Microbiol . 2005 Jan; 43(1):484-7. PMID: 15635022
We described the baseline polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene from 94 treatment-naive patients and the longitudinal follow-up of 17 protease inhibitor-treated patients. Compared to...
7.
Foulongne V, Turriere C, Diafouka F, Abraham B, Lastere S, Segondy M
Acta Virol . 2004 Jul; 48(1):51-5. PMID: 15230476
Human cytomegalovirus (HCMV) resistance to ganciclovir results from mutations in viral phosphotransferase (UL97) and/or DNA polymerase (UL54) genes. The HCMV isolates from the blood of immunocompromised patients with persisting presence...
8.
Griscelli F, Barrois M, Chauvin S, Lastere S, Bellet D, Bourhis J
J Clin Microbiol . 2001 Nov; 39(12):4362-9. PMID: 11724846
A real-time PCR assay was developed to quantify human cytomegalovirus (CMV) DNA in peripheral blood leukocytes (PBLs) of bone marrow transplantation patients. Unlike other teams, we quantified CMV and the...
9.
Abraham B, Lastere S, Reynes J, Bibollet-Ruche F, Vidal N, Segondy M
J Clin Virol . 1999 Aug; 13(3):141-8. PMID: 10443790
Background: Treatment of cytomegalovirus (CMV) diseases with protracted administration of ganciclovir can promote the development of resistant CMV that is associated with a poor response to therapy. It has been...